FSBC vs RARE · P/E 14, rev $139.7M vs rev $350.0M
Five Star Bancorp (FSBC) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Five Star Bancorp (FSBC) is a banks - regional company listed on NASDAQ.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported FSBC revenue for 2026-06-30 was $139.7M. Net income was $38.0M. FSBC currently screens at market cap $963.6M and trailing P/E 14.3.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
FSBC currently screens at market cap $963.6M and trailing P/E 14.3. RARE currently screens at market cap $2.79B.
Not investment advice. Open the FSBC and RARE stock pages for the full models.
Not investment advice.